Trial Profile

Clinical Trial to Assess the Efficacy of Fixed Combination Product Tepilta in the Treatment of Radiation-induced Oesophagitis Compared to Its Active Ingredients Oxetacaine and Antacids, and to Placebo.

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Aluminium hydroxide/magnesium hydroxide/oxetacaine (Primary) ; Aluminium hydroxide/magnesium hydroxide; Oxetacaine
Indications Oesophagitis
Focus Registrational; Therapeutic Use

19 May 2017 Biomarkers information updated
31 Jan 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
17 Jun 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com